

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mannose metabolic process (GO:0006013) | 5.05949881 |
| 2 | negative regulation of cell size (GO:0045792) | 4.38748132 |
| 3 | positive regulation of histone deacetylation (GO:0031065) | 4.09625201 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.01559706 |
| 5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.01559706 |
| 6 | lysine metabolic process (GO:0006553) | 3.99801536 |
| 7 | lysine catabolic process (GO:0006554) | 3.99801536 |
| 8 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.82770293 |
| 9 | regulation of cholesterol homeostasis (GO:2000188) | 3.73503894 |
| 10 | 2-oxoglutarate metabolic process (GO:0006103) | 3.71091990 |
| 11 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.69763079 |
| 12 | negative regulation of cell killing (GO:0031342) | 3.69763079 |
| 13 | regulation of ARF protein signal transduction (GO:0032012) | 3.68444613 |
| 14 | maternal placenta development (GO:0001893) | 3.66142952 |
| 15 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.61762931 |
| 16 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.52270689 |
| 17 | alpha-linolenic acid metabolic process (GO:0036109) | 3.44984216 |
| 18 | carnitine shuttle (GO:0006853) | 3.42479198 |
| 19 | peptidyl-lysine dimethylation (GO:0018027) | 3.42216025 |
| 20 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.39090118 |
| 21 | pre-miRNA processing (GO:0031054) | 3.36503398 |
| 22 | tricarboxylic acid metabolic process (GO:0072350) | 3.35975021 |
| 23 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.28931719 |
| 24 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.28876918 |
| 25 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.23122867 |
| 26 | oxaloacetate metabolic process (GO:0006107) | 3.18148212 |
| 27 | positive thymic T cell selection (GO:0045059) | 3.15593859 |
| 28 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.10045789 |
| 29 | regulation of fatty acid oxidation (GO:0046320) | 3.09820781 |
| 30 | positive regulation of synapse maturation (GO:0090129) | 3.08997489 |
| 31 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.07917853 |
| 32 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.06602556 |
| 33 | fatty acid transmembrane transport (GO:1902001) | 3.04873975 |
| 34 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.03169574 |
| 35 | regulation of extracellular matrix disassembly (GO:0010715) | 3.03079084 |
| 36 | regulation of translational fidelity (GO:0006450) | 2.99992369 |
| 37 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.98219892 |
| 38 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.97684295 |
| 39 | positive regulation of protein deacetylation (GO:0090312) | 2.97492458 |
| 40 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.96734655 |
| 41 | semaphorin-plexin signaling pathway (GO:0071526) | 2.93118757 |
| 42 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.93004005 |
| 43 | T cell selection (GO:0045058) | 2.92559468 |
| 44 | cell-cell junction maintenance (GO:0045217) | 2.89222147 |
| 45 | 4-hydroxyproline metabolic process (GO:0019471) | 2.87433758 |
| 46 | positive regulation of Rap GTPase activity (GO:0032854) | 2.86955756 |
| 47 | valine metabolic process (GO:0006573) | 2.86846199 |
| 48 | regulation of gamma-delta T cell activation (GO:0046643) | 2.86792698 |
| 49 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.85823047 |
| 50 | aspartate family amino acid catabolic process (GO:0009068) | 2.85787267 |
| 51 | sodium ion export (GO:0071436) | 2.85399235 |
| 52 | sarcomere organization (GO:0045214) | 2.83860289 |
| 53 | pentose-phosphate shunt (GO:0006098) | 2.83446705 |
| 54 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.83257206 |
| 55 | negative regulation of nucleotide catabolic process (GO:0030812) | 2.83236703 |
| 56 | adherens junction assembly (GO:0034333) | 2.82010048 |
| 57 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.81304236 |
| 58 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.80296470 |
| 59 | activation of JUN kinase activity (GO:0007257) | 2.80206686 |
| 60 | signal complex assembly (GO:0007172) | 2.79996382 |
| 61 | plasma membrane repair (GO:0001778) | 2.79434293 |
| 62 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.78836200 |
| 63 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.78728431 |
| 64 | focal adhesion assembly (GO:0048041) | 2.77212016 |
| 65 | cell-substrate adherens junction assembly (GO:0007045) | 2.77212016 |
| 66 | histone H4 deacetylation (GO:0070933) | 2.74984954 |
| 67 | negative regulation of heart growth (GO:0061117) | 2.74719920 |
| 68 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.74719920 |
| 69 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.74448967 |
| 70 | response to muramyl dipeptide (GO:0032495) | 2.72279129 |
| 71 | regulation of ARF GTPase activity (GO:0032312) | 2.69060616 |
| 72 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.68238371 |
| 73 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.68169131 |
| 74 | activation of MAPKKK activity (GO:0000185) | 2.68102249 |
| 75 | regulation of synapse maturation (GO:0090128) | 2.67139111 |
| 76 | apoptotic process involved in morphogenesis (GO:0060561) | 2.65966009 |
| 77 | cardiac muscle contraction (GO:0060048) | 2.64086396 |
| 78 | thymic T cell selection (GO:0045061) | 2.64034790 |
| 79 | histone H3 deacetylation (GO:0070932) | 2.63651139 |
| 80 | nucleosome disassembly (GO:0006337) | 2.62098074 |
| 81 | protein-DNA complex disassembly (GO:0032986) | 2.62098074 |
| 82 | positive T cell selection (GO:0043368) | 2.61311991 |
| 83 | negative regulation of sterol transport (GO:0032372) | 2.61000820 |
| 84 | negative regulation of cholesterol transport (GO:0032375) | 2.61000820 |
| 85 | negative thymic T cell selection (GO:0045060) | 2.59424288 |
| 86 | carnitine transmembrane transport (GO:1902603) | 2.59056160 |
| 87 | germinal center formation (GO:0002467) | 2.58832060 |
| 88 | positive regulation of protein dephosphorylation (GO:0035307) | 2.58078686 |
| 89 | glyoxylate metabolic process (GO:0046487) | 2.57567259 |
| 90 | cardiac myofibril assembly (GO:0055003) | 2.56938373 |
| 91 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.54608973 |
| 92 | tricarboxylic acid cycle (GO:0006099) | 2.53574423 |
| 93 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.52750720 |
| 94 | negative regulation of lipid transport (GO:0032369) | 2.52641115 |
| 95 | detection of bacterium (GO:0016045) | 2.51151845 |
| 96 | negative regulation of myotube differentiation (GO:0010832) | 2.50774195 |
| 97 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.49898145 |
| 98 | amino-acid betaine transport (GO:0015838) | 2.49168694 |
| 99 | carnitine transport (GO:0015879) | 2.49168694 |
| 100 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.47552816 |
| 101 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.46586573 |
| 102 | positive regulation of nuclease activity (GO:0032075) | 2.45563645 |
| 103 | modulation by virus of host process (GO:0019054) | 2.44510721 |
| 104 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.44335764 |
| 105 | macrophage activation involved in immune response (GO:0002281) | 2.43661913 |
| 106 | activation of Rac GTPase activity (GO:0032863) | 2.41847251 |
| 107 | negative regulation of purine nucleotide catabolic process (GO:0033122) | 2.41770464 |
| 108 | endothelial cell chemotaxis (GO:0035767) | 2.41520614 |
| 109 | fatty acid homeostasis (GO:0055089) | 2.41506047 |
| 110 | mitotic G1/S transition checkpoint (GO:0044819) | 2.37869341 |
| 111 | negative T cell selection (GO:0043383) | 2.37450954 |
| 112 | nucleotide salvage (GO:0043173) | 2.37012228 |
| 113 | sulfur amino acid catabolic process (GO:0000098) | 2.36956333 |
| 114 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.36684390 |
| 115 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.36588039 |
| 116 | positive regulation of gene expression, epigenetic (GO:0045815) | 2.36576512 |
| 117 | NADH metabolic process (GO:0006734) | 2.36120053 |
| 118 | kynurenine metabolic process (GO:0070189) | 2.35966060 |
| 119 | NADPH regeneration (GO:0006740) | 2.35711879 |
| 120 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.35606658 |
| 121 | L-phenylalanine metabolic process (GO:0006558) | 2.35606658 |
| 122 | regulation of histone H3-K27 methylation (GO:0061085) | 2.35063152 |
| 123 | cellular response to interleukin-4 (GO:0071353) | 2.34675566 |
| 124 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.34557100 |
| 125 | positive regulation of myotube differentiation (GO:0010831) | 2.33989431 |
| 126 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.33985867 |
| 127 | positive regulation of fatty acid oxidation (GO:0046321) | 2.33602858 |
| 128 | response to laminar fluid shear stress (GO:0034616) | 2.32341997 |
| 129 | positive regulation of lamellipodium assembly (GO:0010592) | 2.31270102 |
| 130 | detection of other organism (GO:0098543) | 2.30968021 |
| 131 | cell communication by electrical coupling (GO:0010644) | 2.30850281 |
| 132 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.30709179 |
| 133 | leukocyte aggregation (GO:0070486) | 2.29930275 |
| 134 | regulation of translational termination (GO:0006449) | 2.28706810 |
| 135 | positive regulation of RNA splicing (GO:0033120) | 2.27588709 |
| 136 | natural killer cell differentiation (GO:0001779) | 2.27555069 |
| 137 | histone H4-K16 acetylation (GO:0043984) | 2.26960744 |
| 138 | heterochromatin organization (GO:0070828) | 2.26809305 |
| 139 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.26378028 |
| 140 | negative regulation of RNA splicing (GO:0033119) | 2.26219444 |
| 141 | modulation by symbiont of host cellular process (GO:0044068) | 2.25881047 |
| 142 | cell-substrate junction assembly (GO:0007044) | 2.25604475 |
| 143 | B cell receptor signaling pathway (GO:0050853) | 2.25370321 |
| 144 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.25209033 |
| 145 | regulation of Rap GTPase activity (GO:0032317) | 2.25025889 |
| 146 | diacylglycerol metabolic process (GO:0046339) | 2.24809424 |
| 147 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.23103720 |
| 148 | cell junction maintenance (GO:0034331) | 2.22381564 |
| 149 | activation of protein kinase A activity (GO:0034199) | 2.21468454 |
| 150 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.19699109 |
| 151 | entrainment of circadian clock by photoperiod (GO:0043153) | 2.18944338 |
| 152 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.17744333 |
| 153 | synaptic vesicle exocytosis (GO:0016079) | 2.17708239 |
| 154 | regulation of monocyte differentiation (GO:0045655) | 2.17641457 |
| 155 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.17496747 |
| 156 | Peyers patch development (GO:0048541) | 2.17083224 |
| 157 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.17083224 |
| 158 | negative regulation of granulocyte differentiation (GO:0030853) | 2.16417946 |
| 159 | negative regulation of innate immune response (GO:0045824) | 2.16023243 |
| 160 | positive regulation of protein kinase C signaling (GO:0090037) | 2.15963985 |
| 161 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.15624628 |
| 162 | cell volume homeostasis (GO:0006884) | 2.14926934 |
| 163 | cell migration in hindbrain (GO:0021535) | 2.13701864 |
| 164 | retrograde transport, endosome to Golgi (GO:0042147) | 2.13012085 |
| 165 | histone H4-K12 acetylation (GO:0043983) | 2.12887803 |
| 166 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.12218995 |
| 167 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.12218995 |
| 168 | modulation by symbiont of host immune response (GO:0052553) | 2.12218995 |
| 169 | positive regulation by symbiont of host defense response (GO:0052509) | 2.12218995 |
| 170 | modulation by symbiont of host defense response (GO:0052031) | 2.12218995 |
| 171 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.12218995 |
| 172 | atrioventricular valve morphogenesis (GO:0003181) | 2.11720161 |
| 173 | regulation of leukocyte degranulation (GO:0043300) | 2.11160365 |
| 174 | regulation of extracellular matrix organization (GO:1903053) | 2.10987791 |
| 175 | negative regulation of Ras protein signal transduction (GO:0046580) | 2.10946504 |
| 176 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.10529210 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MYC_22102868_ChIP-Seq_BL_Human | 3.96111625 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.01474009 |
| 3 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.96621561 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.91268161 |
| 5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.83733076 |
| 6 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.65912265 |
| 7 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.60109349 |
| 8 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.58740766 |
| 9 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.58472651 |
| 10 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.40224139 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.39062111 |
| 12 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.30365216 |
| 13 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.29054978 |
| 14 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.25893548 |
| 15 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.20252146 |
| 16 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.16422646 |
| 17 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.09829582 |
| 18 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.07294931 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.94306192 |
| 20 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.92807752 |
| 21 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.91240075 |
| 22 | * MAF_26560356_Chip-Seq_TH1_Human | 1.89300430 |
| 23 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.88694125 |
| 24 | UTX_26944678_Chip-Seq_JUKART_Human | 1.86410574 |
| 25 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.86165307 |
| 26 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.83037255 |
| 27 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.79601539 |
| 28 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.79175663 |
| 29 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.78049082 |
| 30 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.74548954 |
| 31 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.72867727 |
| 32 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.68893376 |
| 33 | KDM2B_26808549_Chip-Seq_K562_Human | 1.64464991 |
| 34 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.64218867 |
| 35 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.63030978 |
| 36 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.59210448 |
| 37 | P68_20966046_ChIP-Seq_HELA_Human | 1.58728255 |
| 38 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.58577936 |
| 39 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.56542728 |
| 40 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.55572355 |
| 41 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.54940716 |
| 42 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.53135432 |
| 43 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.50803525 |
| 44 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.50747146 |
| 45 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.49448990 |
| 46 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.48910225 |
| 47 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.47287287 |
| 48 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.46900980 |
| 49 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.46383498 |
| 50 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.44333793 |
| 51 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.43484836 |
| 52 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.43429234 |
| 53 | MAF_26560356_Chip-Seq_TH2_Human | 1.42434863 |
| 54 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.41366737 |
| 55 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.41041959 |
| 56 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.40817445 |
| 57 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.39772631 |
| 58 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.36225645 |
| 59 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.35908688 |
| 60 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.34011246 |
| 61 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.33251923 |
| 62 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.32572687 |
| 63 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.30830105 |
| 64 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.28920615 |
| 65 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.28397505 |
| 66 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.26969486 |
| 67 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.26061992 |
| 68 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25821835 |
| 69 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.25715272 |
| 70 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.24783695 |
| 71 | ATF3_27146783_Chip-Seq_COLON_Human | 1.24684079 |
| 72 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.24208750 |
| 73 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.24133319 |
| 74 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.23126531 |
| 75 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.22805443 |
| 76 | SA1_27219007_Chip-Seq_Bcells_Human | 1.22734256 |
| 77 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.22451619 |
| 78 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.22401131 |
| 79 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.22134328 |
| 80 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.20790030 |
| 81 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.19596167 |
| 82 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.19561390 |
| 83 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.18417299 |
| 84 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.17740674 |
| 85 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.17697643 |
| 86 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.17695898 |
| 87 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.17039167 |
| 88 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.16988568 |
| 89 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.16983565 |
| 90 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.16697177 |
| 91 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.15573485 |
| 92 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15061434 |
| 93 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.12431657 |
| 94 | SPI1_23127762_ChIP-Seq_K562_Human | 1.11258421 |
| 95 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.11205498 |
| 96 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10824798 |
| 97 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.10381064 |
| 98 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10172681 |
| 99 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.09828268 |
| 100 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.09720756 |
| 101 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.09532517 |
| 102 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.09525241 |
| 103 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09239278 |
| 104 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.09052206 |
| 105 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.08927238 |
| 106 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.07286721 |
| 107 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.06674193 |
| 108 | * PHF8_20622854_ChIP-Seq_HELA_Human | 1.05153511 |
| 109 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.05115150 |
| 110 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.05062018 |
| 111 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.04549173 |
| 112 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.04549173 |
| 113 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04465225 |
| 114 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.04431700 |
| 115 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.04241695 |
| 116 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.03378190 |
| 117 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.03120913 |
| 118 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.02676233 |
| 119 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.02551392 |
| 120 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.02026295 |
| 121 | MYB_26560356_Chip-Seq_TH1_Human | 1.01825914 |
| 122 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.01494311 |
| 123 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01335199 |
| 124 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.00879572 |
| 125 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.00697432 |
| 126 | * JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.00210232 |
| 127 | GATA1_19941826_ChIP-Seq_K562_Human | 0.99593259 |
| 128 | * E2F1_20622854_ChIP-Seq_HELA_Human | 0.98526231 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003705_abnormal_hypodermis_morpholog | 3.19032486 |
| 2 | MP0008961_abnormal_basal_metabolism | 3.09734671 |
| 3 | MP0003172_abnormal_lysosome_physiology | 3.01235172 |
| 4 | MP0003436_decreased_susceptibility_to | 2.96284882 |
| 5 | MP0005360_urolithiasis | 2.93354136 |
| 6 | MP0000751_myopathy | 2.82648483 |
| 7 | MP0005058_abnormal_lysosome_morphology | 2.70334233 |
| 8 | MP0004130_abnormal_muscle_cell | 2.35412529 |
| 9 | MP0005365_abnormal_bile_salt | 2.34351717 |
| 10 | MP0005076_abnormal_cell_differentiation | 2.30651136 |
| 11 | MP0002139_abnormal_hepatobiliary_system | 2.25969020 |
| 12 | MP0002837_dystrophic_cardiac_calcinosis | 2.22532926 |
| 13 | MP0003300_gastrointestinal_ulcer | 2.13708724 |
| 14 | MP0008260_abnormal_autophagy | 2.07239793 |
| 15 | MP0009278_abnormal_bone_marrow | 2.07145403 |
| 16 | MP0003303_peritoneal_inflammation | 2.03065231 |
| 17 | MP0004084_abnormal_cardiac_muscle | 2.02110949 |
| 18 | MP0004087_abnormal_muscle_fiber | 1.98737618 |
| 19 | MP0009840_abnormal_foam_cell | 1.98256015 |
| 20 | MP0002249_abnormal_larynx_morphology | 1.93879892 |
| 21 | MP0005409_darkened_coat_color | 1.91760439 |
| 22 | MP0003183_abnormal_peptide_metabolism | 1.91722252 |
| 23 | MP0000678_abnormal_parathyroid_gland | 1.89077628 |
| 24 | MP0005085_abnormal_gallbladder_physiolo | 1.86860080 |
| 25 | MP0002269_muscular_atrophy | 1.83085045 |
| 26 | MP0010630_abnormal_cardiac_muscle | 1.77370413 |
| 27 | MP0003252_abnormal_bile_duct | 1.77241765 |
| 28 | MP0003646_muscle_fatigue | 1.76236612 |
| 29 | MP0003690_abnormal_glial_cell | 1.73356292 |
| 30 | MP0010352_gastrointestinal_tract_polyps | 1.68351676 |
| 31 | MP0005330_cardiomyopathy | 1.68198940 |
| 32 | MP0000747_muscle_weakness | 1.67307591 |
| 33 | MP0003279_aneurysm | 1.64915005 |
| 34 | MP0002933_joint_inflammation | 1.64486689 |
| 35 | MP0010329_abnormal_lipoprotein_level | 1.63249091 |
| 36 | MP0003879_abnormal_hair_cell | 1.61537971 |
| 37 | MP0002396_abnormal_hematopoietic_system | 1.60457794 |
| 38 | MP0004381_abnormal_hair_follicle | 1.60382392 |
| 39 | MP0004233_abnormal_muscle_weight | 1.57769748 |
| 40 | MP0001849_ear_inflammation | 1.57364518 |
| 41 | MP0004036_abnormal_muscle_relaxation | 1.56662874 |
| 42 | MP0001958_emphysema | 1.54115853 |
| 43 | MP0005083_abnormal_biliary_tract | 1.53755575 |
| 44 | MP0003724_increased_susceptibility_to | 1.53373393 |
| 45 | MP0005666_abnormal_adipose_tissue | 1.51663121 |
| 46 | MP0009333_abnormal_splenocyte_physiolog | 1.51289738 |
| 47 | MP0004185_abnormal_adipocyte_glucose | 1.50603750 |
| 48 | MP0003191_abnormal_cellular_cholesterol | 1.49895169 |
| 49 | MP0004947_skin_inflammation | 1.47649896 |
| 50 | MP0005025_abnormal_response_to | 1.44997744 |
| 51 | MP0002909_abnormal_adrenal_gland | 1.44086002 |
| 52 | MP0001790_abnormal_immune_system | 1.43267111 |
| 53 | MP0005387_immune_system_phenotype | 1.43267111 |
| 54 | MP0001800_abnormal_humoral_immune | 1.42883597 |
| 55 | MP0005451_abnormal_body_composition | 1.42439299 |
| 56 | MP0004808_abnormal_hematopoietic_stem | 1.41211360 |
| 57 | MP0000749_muscle_degeneration | 1.38548523 |
| 58 | MP0002106_abnormal_muscle_physiology | 1.37294164 |
| 59 | MP0005000_abnormal_immune_tolerance | 1.36094393 |
| 60 | MP0005375_adipose_tissue_phenotype | 1.35293946 |
| 61 | MP0000759_abnormal_skeletal_muscle | 1.34709149 |
| 62 | MP0000609_abnormal_liver_physiology | 1.33949175 |
| 63 | MP0000733_abnormal_muscle_development | 1.33576029 |
| 64 | MP0003566_abnormal_cell_adhesion | 1.32955054 |
| 65 | MP0002089_abnormal_postnatal_growth/wei | 1.31481548 |
| 66 | MP0002419_abnormal_innate_immunity | 1.31332148 |
| 67 | MP0006082_CNS_inflammation | 1.28458882 |
| 68 | MP0010155_abnormal_intestine_physiology | 1.26195466 |
| 69 | MP0008569_lethality_at_weaning | 1.26156430 |
| 70 | MP0001502_abnormal_circadian_rhythm | 1.26072520 |
| 71 | MP0003763_abnormal_thymus_physiology | 1.25699577 |
| 72 | MP0001533_abnormal_skeleton_physiology | 1.25003778 |
| 73 | MP0000750_abnormal_muscle_regeneration | 1.24657286 |
| 74 | MP0003221_abnormal_cardiomyocyte_apopto | 1.24322607 |
| 75 | MP0010234_abnormal_vibrissa_follicle | 1.24304561 |
| 76 | MP0002132_abnormal_respiratory_system | 1.23270593 |
| 77 | MP0000685_abnormal_immune_system | 1.22465910 |
| 78 | MP0003283_abnormal_digestive_organ | 1.22026436 |
| 79 | MP0009384_cardiac_valve_regurgitation | 1.19502367 |
| 80 | MP0002420_abnormal_adaptive_immunity | 1.17843928 |
| 81 | MP0002723_abnormal_immune_serum | 1.17436435 |
| 82 | MP0005671_abnormal_response_to | 1.17067203 |
| 83 | MP0002998_abnormal_bone_remodeling | 1.17014449 |
| 84 | MP0001819_abnormal_immune_cell | 1.16817814 |
| 85 | MP0005319_abnormal_enzyme/_coenzyme | 1.16660331 |
| 86 | MP0000003_abnormal_adipose_tissue | 1.13628937 |
| 87 | MP0005670_abnormal_white_adipose | 1.12712625 |
| 88 | MP0001545_abnormal_hematopoietic_system | 1.12274369 |
| 89 | MP0005397_hematopoietic_system_phenotyp | 1.12274369 |
| 90 | MP0003329_amyloid_beta_deposits | 1.09287507 |
| 91 | MP0004145_abnormal_muscle_electrophysio | 1.09149627 |
| 92 | MP0004859_abnormal_synaptic_plasticity | 1.07184754 |
| 93 | MP0008875_abnormal_xenobiotic_pharmacok | 1.06192301 |
| 94 | MP0001730_embryonic_growth_arrest | 1.04003831 |
| 95 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.03826697 |
| 96 | MP0002452_abnormal_antigen_presenting | 1.02498150 |
| 97 | MP0009672_abnormal_birth_weight | 1.01881814 |
| 98 | MP0005385_cardiovascular_system_phenoty | 1.01830645 |
| 99 | MP0001544_abnormal_cardiovascular_syste | 1.01830645 |
| 100 | MP0000858_altered_metastatic_potential | 1.01431001 |
| 101 | MP0000266_abnormal_heart_morphology | 1.00822287 |
| 102 | MP0000703_abnormal_thymus_morphology | 1.00342708 |
| 103 | MP0000604_amyloidosis | 1.00101992 |
| 104 | MP0004197_abnormal_fetal_growth/weight/ | 0.99199963 |
| 105 | MP0003806_abnormal_nucleotide_metabolis | 0.98935849 |
| 106 | MP0001835_abnormal_antigen_presentation | 0.98141665 |
| 107 | MP0003635_abnormal_synaptic_transmissio | 0.97008500 |
| 108 | MP0005423_abnormal_somatic_nervous | 0.96635974 |
| 109 | MP0008770_decreased_survivor_rate | 0.96407696 |
| 110 | MP0002405_respiratory_system_inflammati | 0.96337105 |
| 111 | MP0002118_abnormal_lipid_homeostasis | 0.95765770 |
| 112 | MP0000716_abnormal_immune_system | 0.95629272 |
| 113 | MP0002970_abnormal_white_adipose | 0.95508597 |
| 114 | MP0004858_abnormal_nervous_system | 0.95424624 |
| 115 | MP0002234_abnormal_pharynx_morphology | 0.94500390 |
| 116 | MP0000598_abnormal_liver_morphology | 0.94486980 |
| 117 | MP0003091_abnormal_cell_migration | 0.93877177 |
| 118 | MP0003567_abnormal_fetal_cardiomyocyte | 0.93653992 |
| 119 | MP0002971_abnormal_brown_adipose | 0.92988031 |
| 120 | MP0006036_abnormal_mitochondrial_physio | 0.92163556 |
| 121 | MP0005332_abnormal_amino_acid | 0.91781825 |
| 122 | MP0002398_abnormal_bone_marrow | 0.91468884 |
| 123 | MP0005369_muscle_phenotype | 0.90343213 |
| 124 | MP0004510_myositis | 0.89496992 |
| 125 | MP0001666_abnormal_nutrient_absorption | 0.88699036 |
| 126 | MP0003045_fibrosis | 0.88451627 |
| 127 | MP0000681_abnormal_thyroid_gland | 0.86882678 |
| 128 | MP0005620_abnormal_muscle_contractility | 0.86450384 |
| 129 | MP0001986_abnormal_taste_sensitivity | 0.85844740 |
| 130 | MP0002722_abnormal_immune_system | 0.84645710 |
| 131 | MP0002063_abnormal_learning/memory/cond | 0.83691096 |
| 132 | MP0003866_abnormal_defecation | 0.82891940 |
| 133 | MP0000013_abnormal_adipose_tissue | 0.82496315 |
| 134 | MP0002086_abnormal_extraembryonic_tissu | 0.82321484 |
| 135 | MP0001765_abnormal_ion_homeostasis | 0.82296550 |
| 136 | MP0002088_abnormal_embryonic_growth/wei | 0.81981973 |
| 137 | MP0000767_abnormal_smooth_muscle | 0.81915271 |
| 138 | MP0003984_embryonic_growth_retardation | 0.81727855 |
| 139 | MP0002254_reproductive_system_inflammat | 0.80764339 |
| 140 | MP0000920_abnormal_myelination | 0.80668371 |
| 141 | MP0001663_abnormal_digestive_system | 0.80653782 |
| 142 | MP0001348_abnormal_lacrimal_gland | 0.80316330 |
| 143 | MP0002080_prenatal_lethality | 0.79923977 |
| 144 | MP0005166_decreased_susceptibility_to | 0.79706078 |
| 145 | MP0004215_abnormal_myocardial_fiber | 0.79313156 |
| 146 | MP0005023_abnormal_wound_healing | 0.79301678 |
| 147 | MP0006138_congestive_heart_failure | 0.78368631 |
| 148 | MP0000689_abnormal_spleen_morphology | 0.78102551 |
| 149 | MP0001873_stomach_inflammation | 0.77075073 |
| 150 | MP0002653_abnormal_ependyma_morphology | 0.76944757 |
| 151 | MP0002822_catalepsy | 0.76138654 |
| 152 | MP0008874_decreased_physiological_sensi | 0.75558743 |
| 153 | MP0010368_abnormal_lymphatic_system | 0.75309207 |
| 154 | MP0003453_abnormal_keratinocyte_physiol | 0.74805703 |
| 155 | MP0002429_abnormal_blood_cell | 0.74801762 |
| 156 | MP0005390_skeleton_phenotype | 0.74622300 |
| 157 | MP0003115_abnormal_respiratory_system | 0.73731474 |
| 158 | MP0003119_abnormal_digestive_system | 0.72065165 |
| 159 | MP0002972_abnormal_cardiac_muscle | 0.72023476 |
| 160 | MP0005464_abnormal_platelet_physiology | 0.71371361 |
| 161 | MP0005535_abnormal_body_temperature | 0.69919940 |
| 162 | MP0003634_abnormal_glial_cell | 0.69365429 |
| 163 | MP0002064_seizures | 0.66545709 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Obstructive sleep apnea (HP:0002870) | 4.90848698 |
| 2 | Hyperacusis (HP:0010780) | 4.18720303 |
| 3 | Exercise-induced myalgia (HP:0003738) | 3.44020358 |
| 4 | Abnormality of the lower motor neuron (HP:0002366) | 3.41888226 |
| 5 | Thin bony cortex (HP:0002753) | 3.24364510 |
| 6 | Myoglobinuria (HP:0002913) | 3.09330623 |
| 7 | Broad face (HP:0000283) | 3.01800105 |
| 8 | Stridor (HP:0010307) | 2.97288569 |
| 9 | Exercise-induced muscle cramps (HP:0003710) | 2.91299342 |
| 10 | Eczematoid dermatitis (HP:0000976) | 2.87548704 |
| 11 | Cerebral aneurysm (HP:0004944) | 2.87485694 |
| 12 | Difficulty running (HP:0009046) | 2.79947799 |
| 13 | Supranuclear gaze palsy (HP:0000605) | 2.76855203 |
| 14 | Hemorrhage of the eye (HP:0011885) | 2.75039822 |
| 15 | J-shaped sella turcica (HP:0002680) | 2.74611138 |
| 16 | Sudden death (HP:0001699) | 2.72022275 |
| 17 | Deep venous thrombosis (HP:0002625) | 2.70721903 |
| 18 | Insomnia (HP:0100785) | 2.69350338 |
| 19 | Upper limb amyotrophy (HP:0009129) | 2.65371827 |
| 20 | Distal upper limb amyotrophy (HP:0007149) | 2.65371827 |
| 21 | Elfin facies (HP:0004428) | 2.62598705 |
| 22 | Lymphangioma (HP:0100764) | 2.61254765 |
| 23 | Cervical subluxation (HP:0003308) | 2.53461433 |
| 24 | Asymmetric septal hypertrophy (HP:0001670) | 2.48442714 |
| 25 | Ketosis (HP:0001946) | 2.47336948 |
| 26 | Dysostosis multiplex (HP:0000943) | 2.44218121 |
| 27 | Dysmetric saccades (HP:0000641) | 2.43556835 |
| 28 | Hand muscle atrophy (HP:0009130) | 2.41917247 |
| 29 | Hyporeflexia of lower limbs (HP:0002600) | 2.41492121 |
| 30 | Increased connective tissue (HP:0009025) | 2.40468243 |
| 31 | Ulnar deviation of the wrist (HP:0003049) | 2.39627821 |
| 32 | Biconcave vertebral bodies (HP:0004586) | 2.39242166 |
| 33 | Ketoacidosis (HP:0001993) | 2.39167563 |
| 34 | Emphysema (HP:0002097) | 2.38647698 |
| 35 | Ankle clonus (HP:0011448) | 2.37527241 |
| 36 | Difficulty climbing stairs (HP:0003551) | 2.35229756 |
| 37 | Distal lower limb amyotrophy (HP:0008944) | 2.34042564 |
| 38 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.31547893 |
| 39 | Mucopolysacchariduria (HP:0008155) | 2.31547893 |
| 40 | Type 1 muscle fiber predominance (HP:0003803) | 2.30371065 |
| 41 | Renovascular hypertension (HP:0100817) | 2.29282304 |
| 42 | Easy fatigability (HP:0003388) | 2.29222611 |
| 43 | Spinal canal stenosis (HP:0003416) | 2.27414041 |
| 44 | Papilledema (HP:0001085) | 2.26775495 |
| 45 | Metaphyseal cupping (HP:0003021) | 2.26584558 |
| 46 | Ventricular tachycardia (HP:0004756) | 2.25351243 |
| 47 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.22732757 |
| 48 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.22732757 |
| 49 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.22732757 |
| 50 | Increased IgE level (HP:0003212) | 2.21562142 |
| 51 | Joint stiffness (HP:0001387) | 2.21338742 |
| 52 | Hypercortisolism (HP:0001578) | 2.21103100 |
| 53 | Rhabdomyolysis (HP:0003201) | 2.20935083 |
| 54 | EMG: neuropathic changes (HP:0003445) | 2.19536735 |
| 55 | Ependymoma (HP:0002888) | 2.16308945 |
| 56 | Limb-girdle muscle atrophy (HP:0003797) | 2.15868867 |
| 57 | Cellulitis (HP:0100658) | 2.15607144 |
| 58 | Abnormality of the Achilles tendon (HP:0005109) | 2.15082033 |
| 59 | Atrioventricular block (HP:0001678) | 2.14429636 |
| 60 | Subaortic stenosis (HP:0001682) | 2.12079568 |
| 61 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.12079568 |
| 62 | Polycythemia (HP:0001901) | 2.11430571 |
| 63 | Abnormality of the thoracic spine (HP:0100711) | 2.10576341 |
| 64 | Macroorchidism (HP:0000053) | 2.10443067 |
| 65 | Gastrointestinal infarctions (HP:0005244) | 2.09888722 |
| 66 | Renal duplication (HP:0000075) | 2.09203212 |
| 67 | Disproportionate tall stature (HP:0001519) | 2.08238962 |
| 68 | Broad metatarsal (HP:0001783) | 2.08056541 |
| 69 | Myositis (HP:0100614) | 2.06311998 |
| 70 | Pointed chin (HP:0000307) | 2.06242293 |
| 71 | Verrucae (HP:0200043) | 2.06124104 |
| 72 | Papilloma (HP:0012740) | 2.06124104 |
| 73 | Flat acetabular roof (HP:0003180) | 2.05435225 |
| 74 | Enlarged penis (HP:0000040) | 2.04732475 |
| 75 | Bundle branch block (HP:0011710) | 2.04601490 |
| 76 | Achilles tendon contracture (HP:0001771) | 2.03106991 |
| 77 | Malnutrition (HP:0004395) | 2.01448369 |
| 78 | Mitral regurgitation (HP:0001653) | 2.00684784 |
| 79 | Myopathic facies (HP:0002058) | 2.00489254 |
| 80 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.00396242 |
| 81 | Long toe (HP:0010511) | 1.99950492 |
| 82 | Neurofibrillary tangles (HP:0002185) | 1.99933075 |
| 83 | Frequent falls (HP:0002359) | 1.99539812 |
| 84 | Late onset (HP:0003584) | 1.99232550 |
| 85 | Aneurysm (HP:0002617) | 1.98730947 |
| 86 | Turricephaly (HP:0000262) | 1.98417124 |
| 87 | Gastrointestinal stroma tumor (HP:0100723) | 1.97369407 |
| 88 | Increased variability in muscle fiber diameter (HP:0003557) | 1.95686736 |
| 89 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.95671933 |
| 90 | Angiofibromas (HP:0010615) | 1.95195188 |
| 91 | Adenoma sebaceum (HP:0009720) | 1.95195188 |
| 92 | Polygenic inheritance (HP:0010982) | 1.94722472 |
| 93 | Bronchomalacia (HP:0002780) | 1.94418181 |
| 94 | Abnormality of the nasal mucosa (HP:0000433) | 1.94336201 |
| 95 | Pseudobulbar signs (HP:0002200) | 1.93924042 |
| 96 | Neoplasm of the heart (HP:0100544) | 1.93087987 |
| 97 | Atelectasis (HP:0100750) | 1.90691425 |
| 98 | Abnormality of the fingertips (HP:0001211) | 1.90109917 |
| 99 | Round ear (HP:0100830) | 1.89801066 |
| 100 | EMG: myopathic abnormalities (HP:0003458) | 1.88890433 |
| 101 | Neuronal loss in central nervous system (HP:0002529) | 1.87290148 |
| 102 | Hyperammonemia (HP:0001987) | 1.87175005 |
| 103 | Thin ribs (HP:0000883) | 1.86135916 |
| 104 | Ragged-red muscle fibers (HP:0003200) | 1.85692275 |
| 105 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.85634808 |
| 106 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.85606117 |
| 107 | Thoracic kyphosis (HP:0002942) | 1.85585046 |
| 108 | Inflammation of the large intestine (HP:0002037) | 1.85570545 |
| 109 | Agammaglobulinemia (HP:0004432) | 1.85549381 |
| 110 | Neonatal onset (HP:0003623) | 1.85148707 |
| 111 | Multiple enchondromatosis (HP:0005701) | 1.84885125 |
| 112 | Distal lower limb muscle weakness (HP:0009053) | 1.84866705 |
| 113 | Ulnar bowing (HP:0003031) | 1.84396827 |
| 114 | Overriding aorta (HP:0002623) | 1.84374793 |
| 115 | Right ventricular cardiomyopathy (HP:0011663) | 1.83320222 |
| 116 | Onion bulb formation (HP:0003383) | 1.83176172 |
| 117 | Gastrointestinal inflammation (HP:0004386) | 1.82704988 |
| 118 | Colitis (HP:0002583) | 1.82507114 |
| 119 | Nasal polyposis (HP:0100582) | 1.82476404 |
| 120 | Gout (HP:0001997) | 1.82216175 |
| 121 | Muscle fiber inclusion bodies (HP:0100299) | 1.80165735 |
| 122 | Ventricular fibrillation (HP:0001663) | 1.79729448 |
| 123 | Spontaneous hematomas (HP:0007420) | 1.79693466 |
| 124 | Shallow orbits (HP:0000586) | 1.79611909 |
| 125 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.78915804 |
| 126 | Muscle fiber splitting (HP:0003555) | 1.78647479 |
| 127 | Vertebral arch anomaly (HP:0008438) | 1.78099297 |
| 128 | Annular pancreas (HP:0001734) | 1.77852406 |
| 129 | Broad palm (HP:0001169) | 1.76656878 |
| 130 | Hamartoma of the eye (HP:0010568) | 1.76013270 |
| 131 | Long palpebral fissure (HP:0000637) | 1.75974942 |
| 132 | Gingivitis (HP:0000230) | 1.75938214 |
| 133 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.75930430 |
| 134 | Pustule (HP:0200039) | 1.74998376 |
| 135 | Hemiplegia (HP:0002301) | 1.73369827 |
| 136 | Recurrent fungal infections (HP:0002841) | 1.73160139 |
| 137 | Visceral angiomatosis (HP:0100761) | 1.72778854 |
| 138 | Spastic diplegia (HP:0001264) | 1.72507158 |
| 139 | Rectal prolapse (HP:0002035) | 1.72103236 |
| 140 | Hypertriglyceridemia (HP:0002155) | 1.72076765 |
| 141 | Increased density of long bones (HP:0006392) | 1.72050339 |
| 142 | Bulbar palsy (HP:0001283) | 1.70811116 |
| 143 | Calf muscle hypertrophy (HP:0008981) | 1.70153972 |
| 144 | Abnormality of the 4th metacarpal (HP:0010012) | 1.69752022 |
| 145 | Back pain (HP:0003418) | 1.68653405 |
| 146 | Deformed sella turcica (HP:0002681) | 1.68502044 |
| 147 | Supernumerary nipples (HP:0002558) | 1.67870861 |
| 148 | Xanthomatosis (HP:0000991) | 1.67660223 |
| 149 | Lower limb amyotrophy (HP:0007210) | 1.67020206 |
| 150 | Fibroma (HP:0010614) | 1.66928594 |
| 151 | Aortic regurgitation (HP:0001659) | 1.66568143 |
| 152 | Dislocated radial head (HP:0003083) | 1.66480233 |
| 153 | Sleep apnea (HP:0010535) | 1.65935089 |
| 154 | Systemic lupus erythematosus (HP:0002725) | 1.65902073 |
| 155 | Diplopia (HP:0000651) | 1.65610533 |
| 156 | Abnormality of binocular vision (HP:0011514) | 1.65610533 |
| 157 | Gastrointestinal dysmotility (HP:0002579) | 1.65554506 |
| 158 | Growth hormone excess (HP:0000845) | 1.65494059 |
| 159 | Meningitis (HP:0001287) | 1.65489861 |
| 160 | Nuclear cataract (HP:0100018) | 1.65284520 |
| 161 | Heart block (HP:0012722) | 1.63850426 |
| 162 | Precocious puberty (HP:0000826) | 1.63171426 |
| 163 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.62963739 |
| 164 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.62963739 |
| 165 | Myotonia (HP:0002486) | 1.62449088 |
| 166 | Chest pain (HP:0100749) | 1.61657689 |
| 167 | Hypoglycemic coma (HP:0001325) | 1.61102257 |
| 168 | Fibrous tissue neoplasm (HP:0012316) | 1.60354255 |
| 169 | Protrusio acetabuli (HP:0003179) | 1.59204457 |
| 170 | Mesangial abnormality (HP:0001966) | 1.59044031 |
| 171 | Progressive muscle weakness (HP:0003323) | 1.58935397 |
| 172 | Abnormality of the astrocytes (HP:0100707) | 1.58779424 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 5.19009565 |
| 2 | PKN2 | 4.25502571 |
| 3 | MAP3K10 | 3.70338537 |
| 4 | EEF2K | 3.54645788 |
| 5 | ERN1 | 3.11040766 |
| 6 | PRPF4B | 3.02596358 |
| 7 | TTN | 2.39165303 |
| 8 | MAP3K13 | 2.16026836 |
| 9 | MAP4K1 | 2.09497941 |
| 10 | SIK2 | 2.08714630 |
| 11 | SMG1 | 2.05464910 |
| 12 | SIK1 | 1.95629805 |
| 13 | TAOK1 | 1.95498636 |
| 14 | RIPK4 | 1.88672164 |
| 15 | RIPK1 | 1.88324411 |
| 16 | BCKDK | 1.84209919 |
| 17 | ICK | 1.82125224 |
| 18 | TNK2 | 1.79511411 |
| 19 | CDK12 | 1.79292541 |
| 20 | FGFR4 | 1.70197409 |
| 21 | PTK6 | 1.68360318 |
| 22 | MAP3K7 | 1.60625806 |
| 23 | LRRK2 | 1.58817100 |
| 24 | GRK6 | 1.52559722 |
| 25 | LMTK2 | 1.47036120 |
| 26 | NEK1 | 1.35868440 |
| 27 | TYRO3 | 1.34855900 |
| 28 | MAP2K3 | 1.25662584 |
| 29 | ALK | 1.13607347 |
| 30 | PDGFRA | 1.12261974 |
| 31 | PHKG2 | 1.12046342 |
| 32 | PHKG1 | 1.12046342 |
| 33 | MAPK15 | 1.09802317 |
| 34 | PRKD3 | 1.05588901 |
| 35 | MTOR | 1.05574017 |
| 36 | FLT3 | 1.03953211 |
| 37 | DMPK | 1.00598449 |
| 38 | STK10 | 0.98441039 |
| 39 | MARK2 | 0.94436653 |
| 40 | ZAP70 | 0.94302763 |
| 41 | NEK2 | 0.93773698 |
| 42 | IRAK4 | 0.93539998 |
| 43 | CDK4 | 0.90070290 |
| 44 | BLK | 0.89602998 |
| 45 | MAP2K2 | 0.89536590 |
| 46 | CAMK1G | 0.87748348 |
| 47 | RPS6KC1 | 0.86721089 |
| 48 | RPS6KL1 | 0.86721089 |
| 49 | KSR2 | 0.86633954 |
| 50 | RET | 0.82819535 |
| 51 | NTRK3 | 0.82503732 |
| 52 | MAP3K3 | 0.80741359 |
| 53 | PRKCH | 0.80684706 |
| 54 | PAK4 | 0.80555385 |
| 55 | CAMKK1 | 0.80278191 |
| 56 | BMX | 0.80007956 |
| 57 | MAPK7 | 0.78680864 |
| 58 | MAP3K1 | 0.78578260 |
| 59 | MAP3K9 | 0.78454927 |
| 60 | TYK2 | 0.77742306 |
| 61 | CSK | 0.77051640 |
| 62 | MAP3K14 | 0.76911559 |
| 63 | JAK3 | 0.76529240 |
| 64 | CAMK1D | 0.75317098 |
| 65 | TGFBR2 | 0.74457539 |
| 66 | DYRK1B | 0.73718221 |
| 67 | SIK3 | 0.73701240 |
| 68 | MAPK11 | 0.73549182 |
| 69 | MAPKAPK3 | 0.73351031 |
| 70 | DAPK2 | 0.72926090 |
| 71 | MAP3K6 | 0.72604898 |
| 72 | RPS6KA6 | 0.72350799 |
| 73 | RPS6KB2 | 0.72280738 |
| 74 | MAP3K11 | 0.71928384 |
| 75 | BTK | 0.70011576 |
| 76 | TGFBR1 | 0.69319825 |
| 77 | PRKD2 | 0.65888257 |
| 78 | CDK6 | 0.65457187 |
| 79 | ILK | 0.64970571 |
| 80 | NTRK1 | 0.63299847 |
| 81 | HCK | 0.62937876 |
| 82 | SCYL2 | 0.62842711 |
| 83 | PAK6 | 0.62258708 |
| 84 | MAPK12 | 0.59564818 |
| 85 | PDK1 | 0.59375536 |
| 86 | JAK1 | 0.58989186 |
| 87 | PTK2 | 0.57849235 |
| 88 | JAK2 | 0.57197570 |
| 89 | FGFR3 | 0.57166313 |
| 90 | EPHB1 | 0.56924565 |
| 91 | NTRK2 | 0.54885757 |
| 92 | CSF1R | 0.54865544 |
| 93 | PAK2 | 0.54422033 |
| 94 | STK38 | 0.53947315 |
| 95 | IKBKE | 0.53591635 |
| 96 | HIPK2 | 0.53437910 |
| 97 | MAP3K8 | 0.53189816 |
| 98 | ITK | 0.51620237 |
| 99 | TBK1 | 0.51574989 |
| 100 | DDR2 | 0.51399591 |
| 101 | CAMK4 | 0.50944492 |
| 102 | CDC42BPA | 0.50448424 |
| 103 | PRKD1 | 0.49513593 |
| 104 | SGK223 | 0.49184807 |
| 105 | SGK494 | 0.49184807 |
| 106 | DAPK1 | 0.48286779 |
| 107 | TAOK2 | 0.45976036 |
| 108 | PDK3 | 0.45746785 |
| 109 | PDK4 | 0.45746785 |
| 110 | EPHA2 | 0.44857776 |
| 111 | MAPK4 | 0.44309283 |
| 112 | RPS6KA2 | 0.44290631 |
| 113 | FGR | 0.43742766 |
| 114 | SYK | 0.43637737 |
| 115 | LCK | 0.42627632 |
| 116 | IRAK3 | 0.41547574 |
| 117 | PDPK1 | 0.41538460 |
| 118 | KSR1 | 0.41152590 |
| 119 | RPS6KA1 | 0.40865177 |
| 120 | CAMK1 | 0.40624716 |
| 121 | STK11 | 0.40305754 |
| 122 | PRKAA1 | 0.40059484 |
| 123 | FYN | 0.39944684 |
| 124 | IRAK2 | 0.39755120 |
| 125 | MAP2K4 | 0.39713635 |
| 126 | MARK3 | 0.39692779 |
| 127 | UHMK1 | 0.39136580 |
| 128 | TESK1 | 0.38970748 |
| 129 | MAP2K6 | 0.38801410 |
| 130 | SGK3 | 0.38352844 |
| 131 | MAPK8 | 0.38119037 |
| 132 | BRD4 | 0.37909147 |
| 133 | AKT2 | 0.37906834 |
| 134 | FGFR1 | 0.37372624 |
| 135 | LATS2 | 0.35632829 |
| 136 | FES | 0.35465017 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.40354928 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.99757067 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.89317926 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.84821704 |
| 5 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.51171908 |
| 6 | Lysine degradation_Homo sapiens_hsa00310 | 2.15672422 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.06219648 |
| 8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.93448372 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.68131259 |
| 10 | Carbon metabolism_Homo sapiens_hsa01200 | 1.67484228 |
| 11 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.66232055 |
| 12 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.64914232 |
| 13 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.58315867 |
| 14 | Insulin resistance_Homo sapiens_hsa04931 | 1.54221324 |
| 15 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.51185007 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.47236174 |
| 17 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.37438413 |
| 18 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.36649916 |
| 19 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.34221421 |
| 20 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.33537213 |
| 21 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.33476242 |
| 22 | Bile secretion_Homo sapiens_hsa04976 | 1.33313574 |
| 23 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.31715353 |
| 24 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.31041991 |
| 25 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.29276543 |
| 26 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.25410696 |
| 27 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.24968244 |
| 28 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.24924716 |
| 29 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.20966282 |
| 30 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.20665547 |
| 31 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.19778735 |
| 32 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.19465511 |
| 33 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.18584162 |
| 34 | Long-term potentiation_Homo sapiens_hsa04720 | 1.17828865 |
| 35 | Leishmaniasis_Homo sapiens_hsa05140 | 1.17632340 |
| 36 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.17392694 |
| 37 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.14740092 |
| 38 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.13462575 |
| 39 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.11880299 |
| 40 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.10421361 |
| 41 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.10193100 |
| 42 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.07440982 |
| 43 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.06800915 |
| 44 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.05615164 |
| 45 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.04747160 |
| 46 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.04641187 |
| 47 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.04301937 |
| 48 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.03947649 |
| 49 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.03625084 |
| 50 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.01792765 |
| 51 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.01096423 |
| 52 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.00018603 |
| 53 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.99880230 |
| 54 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.97072625 |
| 55 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.96086759 |
| 56 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.95421268 |
| 57 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.94271398 |
| 58 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.93904031 |
| 59 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.92598452 |
| 60 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.91731259 |
| 61 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.91586534 |
| 62 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.91380624 |
| 63 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.91379626 |
| 64 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.91312048 |
| 65 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.90554851 |
| 66 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.90422251 |
| 67 | Viral myocarditis_Homo sapiens_hsa05416 | 0.88995130 |
| 68 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.88136442 |
| 69 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.87891808 |
| 70 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.87064220 |
| 71 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.86578527 |
| 72 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.86398665 |
| 73 | Prion diseases_Homo sapiens_hsa05020 | 0.86200388 |
| 74 | Endometrial cancer_Homo sapiens_hsa05213 | 0.85940566 |
| 75 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.85366023 |
| 76 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.85220992 |
| 77 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.84436158 |
| 78 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.82679006 |
| 79 | Endocytosis_Homo sapiens_hsa04144 | 0.81235410 |
| 80 | Hepatitis C_Homo sapiens_hsa05160 | 0.80764946 |
| 81 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.79770559 |
| 82 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.79209989 |
| 83 | Tuberculosis_Homo sapiens_hsa05152 | 0.78484010 |
| 84 | Glioma_Homo sapiens_hsa05214 | 0.78105850 |
| 85 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.76602205 |
| 86 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.76576346 |
| 87 | Galactose metabolism_Homo sapiens_hsa00052 | 0.74206850 |
| 88 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.73860926 |
| 89 | Insulin secretion_Homo sapiens_hsa04911 | 0.72415557 |
| 90 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.70332588 |
| 91 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.70073448 |
| 92 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.68036605 |
| 93 | Influenza A_Homo sapiens_hsa05164 | 0.67698948 |
| 94 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.67417361 |
| 95 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.67177633 |
| 96 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.65292114 |
| 97 | Thyroid cancer_Homo sapiens_hsa05216 | 0.65255072 |
| 98 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.64318311 |
| 99 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.63411104 |
| 100 | Melanogenesis_Homo sapiens_hsa04916 | 0.63209340 |
| 101 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.62753141 |
| 102 | Platelet activation_Homo sapiens_hsa04611 | 0.62447713 |
| 103 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.62362244 |
| 104 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.61841718 |
| 105 | Sulfur relay system_Homo sapiens_hsa04122 | 0.61759109 |
| 106 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.61582670 |
| 107 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.60934009 |
| 108 | ABC transporters_Homo sapiens_hsa02010 | 0.60387813 |
| 109 | Colorectal cancer_Homo sapiens_hsa05210 | 0.60172004 |
| 110 | Hepatitis B_Homo sapiens_hsa05161 | 0.59562696 |
| 111 | Circadian entrainment_Homo sapiens_hsa04713 | 0.59236603 |
| 112 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.59056961 |
| 113 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.58930282 |
| 114 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.58193050 |
| 115 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.57654528 |
| 116 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.57634613 |
| 117 | Allograft rejection_Homo sapiens_hsa05330 | 0.57528334 |
| 118 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.57465274 |
| 119 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.57425983 |
| 120 | Lysosome_Homo sapiens_hsa04142 | 0.57085380 |
| 121 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.56130275 |
| 122 | Amoebiasis_Homo sapiens_hsa05146 | 0.56005797 |
| 123 | Bladder cancer_Homo sapiens_hsa05219 | 0.55542039 |
| 124 | Focal adhesion_Homo sapiens_hsa04510 | 0.55439099 |
| 125 | Morphine addiction_Homo sapiens_hsa05032 | 0.55295631 |
| 126 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.55279098 |
| 127 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.55020222 |
| 128 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.54295946 |
| 129 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.54041474 |
| 130 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.53985963 |
| 131 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.53424072 |
| 132 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.53177970 |
| 133 | Pertussis_Homo sapiens_hsa05133 | 0.52438363 |
| 134 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.52234617 |
| 135 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.51977733 |
| 136 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.51931658 |
| 137 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.51718628 |
| 138 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.51037416 |
| 139 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.51031200 |
| 140 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.49936369 |
| 141 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.49527638 |
| 142 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.48044022 |
| 143 | HTLV-I infection_Homo sapiens_hsa05166 | 0.46305763 |
| 144 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.45898177 |
| 145 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.45821966 |
| 146 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.44802926 |
| 147 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.44702534 |
| 148 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.44525007 |
| 149 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.44337996 |

